TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification

✍ Scribed by Maloney, KW; McGavran, L; Murphy, JR; Odom, LF; Stork, L; Wei, Q; Hunger, SP

• Book ID: 110054332
• Publisher: Nature Publishing Group
• Year: 1999
• Tongue: English
• Weight: 92 KB
• Volume: 13
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2401548